Supported by an educational grant from PharmEssentia and Geron

Click on the link to complete the pre-assessment questions before the session begins: https://mli.link/sohompnpre

SESSION IV: MYELOPROLIFERATIVE NEOPLASMS

Session Chairs: Gabriela Hobbs, MD and John O. Mascarenhas, MD

Novel Therapies in PV and ET | Gabriela Hobbs, MD | Massachusetts General Hospital, Boston, Massachusetts, USA

Anemia Considerations in MF | Aaron T. Gerds, MD | Cleveland Clinic, Cleveland, Ohio, USA

When And How to Optimize JAK Inhibitor Therapy in MF | Francesca Palandri, MD, PhD | University of Bologna, Bologna, Italy

Is Combination Therapy Here for MPNs? | John O. Mascarenhas, MD | Mount Sinai Medical Center, New York, New York, USA

When And Who Should Get a Transplant? | Vikas Gupta, MD, FRCP, FRCPath | Princess Margaret Cancer Centre, Toronto, Canada

Oral Abstract | MPN-642: Glucagon-Like Peptide-1 Agonists and Clinical Outcomes in Polycythemia Vera: A Large-Scale Propensity-Matched Cohort Study | Asfand Yar Cheema, MD | Cleveland Clinic Foundation/Fairview Hospital Cleveland, Ohio, USA